SpliceBio
Biotechnology company exploiting Protein Splicing to develop the next generation of gene therapies.
Spain
39 employees
Series A
Total: $51.70M
Biotechnology, Life Sciences +1
General Information
Get notified when SpliceBio moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track SpliceBio
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Spain Market
Biotechnology
About SpliceBio
Taxonomy: Protein Splicing, Gene Therapies, Platform Technology, Intein, Protein Engineering, Research, Start-up, Investment, UCB Ventures, Ysios Capital, NEA, Gilde Healthcare, Novartis Venture Fund, Asabys Partners
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | •••••• | 6 |
|
15 Feb 2022 |
| Venture Round | •••••• | 2 |
|
15 Sep 2020 |
| Series A | •••••• | 1 |
|
28 Feb 2018 |
Latest News
View All
SpliceBio Alternatives & Competitors
Air Protein is a modern food company, the pioneer in making protein from elements of the air.
We keep it beautifully simple. One step transforms ordinary flour into high-value Happy plant protei...
Bring rapid protein access to your benchtop with eProtein Discovery
FAQ About SpliceBio
Don't just browse. Track.
Signal Tracker monitors SpliceBio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
